Your browser doesn't support javascript.
loading
Pixantrone, etoposide, bendamustine, rituximab (P[R]EBEN) as an effective salvage regimen for relapsed/refractory aggressive non-Hodgkin lymphoma-Polish Lymphoma Research Group real-life analysis.
Dlugosz-Danecka, Monika; Hus, Iwona; Pula, Bartosz; Jurczyszyn, Artur; Chojnacki, Tomasz; Blajer-Olszewska, Beata; Drozd-Sokolowska, Joanna; Razny, Malgorzata; Romejko-Jarosinska, Joanna; Taszner, Michal; Jurczak, Wojciech.
Afiliación
  • Dlugosz-Danecka M; Department of Hematology, Jagiellonian University, Kraków, Poland.
  • Hus I; Department of Clinical Transplantology, Medical University of Lublin, Lublin, Poland. Electronic address: iwonach.hus@gmail.com.
  • Pula B; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warszawa, Poland.
  • Jurczyszyn A; Department of Hematology, Jagiellonian University, Kraków, Poland.
  • Chojnacki T; Department of Hematology, Military Institute of Medicine, Warszawa, Poland.
  • Blajer-Olszewska B; Department of Hematology, Clinical District Chopin Memorial Hospital, Rzeszów, Poland.
  • Drozd-Sokolowska J; Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Warszawa, Poland.
  • Razny M; Department of Hematology, Rydygier Memorial Hospital, Kraków, Poland.
  • Romejko-Jarosinska J; Department of Lymphoproliferative Diseases, Maria Sklodowska-Curie Centre of Oncology and Institute, Warszawa, Poland.
  • Taszner M; Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland.
  • Jurczak W; Department of Hematology, Jagiellonian University, Kraków, Poland.
Pharmacol Rep ; 71(3): 473-477, 2019 Jun.
Article en En | MEDLINE | ID: mdl-31003160

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Etopósido / Clorhidrato de Bendamustina / Rituximab / Isoquinolinas Tipo de estudio: Observational_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: Pharmacol Rep Asunto de la revista: FARMACOLOGIA Año: 2019 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Etopósido / Clorhidrato de Bendamustina / Rituximab / Isoquinolinas Tipo de estudio: Observational_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: Pharmacol Rep Asunto de la revista: FARMACOLOGIA Año: 2019 Tipo del documento: Article